PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma

被引:165
作者
Paiva, B. [1 ,2 ,3 ]
Azpilikueta, A. [2 ]
Puig, N. [4 ]
Ocio, E. M. [4 ]
Sharma, R. [5 ]
Oyajobi, B. O. [5 ]
Labiano, S. [2 ]
San-Segundo, L. [4 ]
Rodriguez, A. [3 ]
Aires-Mejia, I. [4 ]
Rodriguez, I. [2 ]
Escalante, F. [6 ]
de Coca, A. G. [7 ]
Barez, A. [8 ]
San Miguel, J. F. [1 ,2 ,3 ]
Melero, I. [1 ,2 ,3 ]
机构
[1] Univ Navarra Clin, Pamplona, Spain
[2] CIMA, Pamplona, Spain
[3] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain
[4] Hosp Univ Salamanca, IBSAL, IBMCC USAL CSIC, Salamanca, Spain
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[6] Complejo Hosp Leon, Leon, Spain
[7] Hosp Clin Univ Valladolid, Valladolid, Spain
[8] Hosp Nuestra Senora de Sonsoles, Avila, Spain
关键词
ANTIBODY; EXPRESSION; RESPONSES; CELLS;
D O I
10.1038/leu.2015.79
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2110 / 2113
页数:5
相关论文
共 15 条
[1]   The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody [J].
Benson, Don M., Jr. ;
Bakan, Courtney E. ;
Mishra, Anjali ;
Hofmeister, Craig C. ;
Efebera, Yvonne ;
Becknell, Brian ;
Baiocchi, Robert A. ;
Zhang, Jianying ;
Yu, Jianhua ;
Smith, Megan K. ;
Greenfield, Carli N. ;
Porcu, Pierluigi ;
Devine, Steven M. ;
Rotem-Yehudar, Rinat ;
Lozanski, Gerard ;
Byrd, John C. ;
Caligiuri, Michael A. .
BLOOD, 2010, 116 (13) :2286-2294
[2]   Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade [J].
Hallett, William H. D. ;
Jing, Weiqing ;
Drobyski, William R. ;
Johnson, Bryon D. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (08) :1133-1145
[3]   Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients [J].
Herbst, Roy S. ;
Soria, Jean-Charles ;
Kowanetz, Marcin ;
Fine, Gregg D. ;
Hamid, Omid ;
Gordon, Michael S. ;
Sosman, Jeffery A. ;
McDermott, David F. ;
Powderly, John D. ;
Gettinger, Scott N. ;
Kohrt, Holbrook E. K. ;
Horn, Leora ;
Lawrence, Donald P. ;
Rost, Sandra ;
Leabman, Maya ;
Xiao, Yuanyuan ;
Mokatrin, Ahmad ;
Koeppen, Hartmut ;
Hegde, Priti S. ;
Mellman, Ira ;
Chen, Daniel S. ;
Hodi, F. Stephen .
NATURE, 2014, 515 (7528) :563-+
[4]   Programmed Death Receptor-1/Programmed Death Receptor Ligand-1 Blockade after Transient Lymphodepletion To Treat Myeloma [J].
Kearl, Tyce J. ;
Jing, Weiqing ;
Gershan, Jill A. ;
Johnson, Bryon D. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (11) :5620-5628
[5]   Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway [J].
Liu, Jizhong ;
Hamrouni, Abdelbasset ;
Wolowiec, Darius ;
Coiteux, Valrie ;
Kuliczkowski, Kazirnierz ;
Hetuin, Dominique ;
Saudemont, Aurore ;
Quesnel, Bruno .
BLOOD, 2007, 110 (01) :296-304
[6]   Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination [J].
Melero, Ignacio ;
Grimaldi, Antonio M. ;
Perez-Gracia, Jose L. ;
Ascierto, Paolo A. .
CLINICAL CANCER RESEARCH, 2013, 19 (05) :997-1008
[7]   Therapeutic Antitumor Efficacy of Anti-CD137 Agonistic Monoclonal Antibody in Mouse Models of Myeloma [J].
Murillo, Oihana ;
Arina, Ainhoa ;
Hervas-Stubbs, Sandra ;
Gupta, Anjana ;
McCluskey, Brandon ;
Dubrot, Juan ;
Palazon, Asis ;
Azpilikueta, Arantza ;
Ochoa, Maria C. ;
Alfaro, Carlos ;
Solano, Sarai ;
Perez-Gracia, Jose L. ;
Oyajobi, Babatunde O. ;
Melero, Ignacio .
CLINICAL CANCER RESEARCH, 2008, 14 (21) :6895-6906
[8]   New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) [J].
Ocio, E. M. ;
Richardson, P. G. ;
Rajkumar, S. V. ;
Palumbo, A. ;
Mateos, M. V. ;
Orlowski, R. ;
Kumar, S. ;
Usmani, S. ;
Roodman, D. ;
Niesvizky, R. ;
Einsele, H. ;
Anderson, K. C. ;
Dimopoulos, M. A. ;
Avet-Loiseau, H. ;
Mellqvist, U-H ;
Turesson, I. ;
Merlini, G. ;
Schots, R. ;
McCarthy, P. ;
Bergsagel, L. ;
Chim, C. S. ;
Lahuerta, J. J. ;
Shah, J. ;
Reiman, A. ;
Mikhael, J. ;
Zweegman, S. ;
Lonial, S. ;
Comenzo, R. ;
Chng, W. J. ;
Moreau, P. ;
Sonneveld, P. ;
Ludwig, H. ;
Durie, B. G. M. ;
Miguel, J. F. S. .
LEUKEMIA, 2014, 28 (03) :525-542
[9]   A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control [J].
Paiva, B. ;
Vidriales, M-B ;
Rosinol, L. ;
Martinez-Lopez, J. ;
Mateos, M-V ;
Ocio, E. M. ;
Montalban, M-A ;
Cordon, L. ;
Gutierrez, N. C. ;
Corchete, L. ;
Oriol, A. ;
Terol, M-J ;
Echeveste, M-A ;
De Paz, R. ;
De Arriba, F. ;
Palomera, L. ;
de la Rubia, J. ;
Diaz-Mediavilla, J. ;
Granell, M. ;
Gorosquieta, A. ;
Alegre, A. ;
Orfao, A. ;
Lahuerta, J-J ;
Blade, J. ;
San Miguel, J. F. .
LEUKEMIA, 2013, 27 (10) :2056-2061
[10]   The blockade of immune checkpoints in cancer immunotherapy [J].
Pardoll, Drew M. .
NATURE REVIEWS CANCER, 2012, 12 (04) :252-264